June 24–26, 2027, Rome, Italy

Scientific Program · Heart Congress 2024

Heart Congress 2024 — Scientific Program

Day-by-day session and presentation schedule

The full Heart Congress 2024 scientific program across 3 days — keynotes, oral presentations, and posters. Talks are ordered by program prominence within each day.

Day 1

Day 1

  1. Keynote

    Managing total chronic coronary occlusion: Noninvasive External Counterpulsation (ECP) induces collaterogenesis, relieving ischemia, as demonstrated by quantitative PET myocardial perfusion imaging: ECP is a cost-effective alternative to high risk PCI

    Michael E Merhige · State University of NY at Buffalo, United States

    Background: External Counter Pulsation (ECP) is an FDA approved, noninvasive, treatment for patients with refractory angina, who are not candidates for low-risk interventional revascularization, such as those with…

  2. Keynote

    Novel signaling pathways and therapeutic options for pulmonary hypertension

    Yong Xiao Wang · Albany Medical College, United States

    Pulmonary hypertension (PH) is a common and devastating lung disease. The current primary medications for this disease are to use non-specific vasodilators, but patients do not always respond well to non-specific…

  3. Keynote

    Personalized and Precision Medicine (PPM) as a unique healthcare model to be set up through biodesign-inspired and biotech-driven translational applications and cardiology-related marketing to secure the human healthcare and biosafety

    Sergey Suchkov · N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

    A new systems approach to diseased states and wellness result in a new branch in the healthcare ser-vices, namely Personalized and Precision Medicine (PPM). To achieve the implementation of PPM concept, it is necessary…

  4. Keynote

    How do nutraceuticals protect against heart disease?

    Dipak P Ramji · Cardiff University, United Kingdom

    Atherosclerosclerotic cardiovascular disease (ACVD) is responsible for a third of all global deaths. Although a reduction in morbidity and mortality from ACVD has been achieved recently by lifestyle changes and…

  5. Keynote · Virtual

    Ambulatory blood pressure monitoring in patients with diabetic nephropathy

    Samia Barbouch · Charles Nicolle Hospital, Tunisia

    Diabetic nephropathy (DN) is the main cause of renal failure worldwide. DN is often associated with high blood pressure (BP), and these two pathologies seem to maintain each other. However, the impact of this…

  6. Oral

    Cuffless blood pressure monitoring using multiple artificial intelligence models

    Prabode Weebadde · Purdue University, United States

    In the U.S., every year, about 800,000 people die due to cardiovascular diseases (CVD) or diseases related to the heart and blood vessels. Of those 800,000, 650,000 deaths were related to the heart, and 150,000 were…

  7. Oral

    The cardiovascular hospitalist, a paradigm shift: Impact of specialty hospitalists on clinical, financial, and operational care delivery in a large us health care institution (Intermountain Health)

    Blake I Gardner · Intermountain Health, United States

    Intermountain Health is a large integrated healthcare institution in the western United States that prioritizes value-based care, even at times when it appears contrary to regional and national payment models. Because…

  8. Oral

    Antibodies with functionality as a new generation of translational tools designed to monitor autoimmune myocarditis at clinical and subclinical stages

    Sergey Suchkov · N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

    Catalytic Abs (catAbs) are multivalent immunoglobulins (Igs) with a capacity to hydrolyze the antigenic (Ag) substrate. In this sense, proteolytic Abs (Ab-proteases) represent Abs to provide proteolytic effects.…

  9. Oral

    Multidisciplinary approach to cardiovascular patient

    Lusine Harutyunyan · Adventist Health, United States

    Importance on multidisciplinary approach to cardiovascular patients- specifically ASCVD and CHF groups. Financial and socioeconomic burden of cardiovascular disease and ways to improve patient outcomes and patient…

  10. Oral

    Modeling human heart development and congenital disease using an iPSC-based 3D bioprinted model of embryonic human heart

    Vahid Serpooshan · Emory University and Georgia Institute of Technology, United States

    Human cardiogenesis is a finely orchestrated process that involves dynamic genetic and morphological changes. However, the cellular and microenvironmental processes underlying the human heart development remain obscure…

  11. Oral

    IV Iron in heart failure -A Quality Improvement Project (QIP)

    Qazi Naeem ur Rehman · Wirral University Teaching Hospital NHS Foundation Trust Wirral, United Kingdom

    Introduction : Heart failure affects more than 64 million people worldwide and causes significant morbidity and mortality. The prevalence of iron deficiency (ID) can reach up to 59% in patients with heart failure. ID is…

  12. Oral

    Unlocking the cardiac vector theory and einthoven equilateral triangle model: A paradigm shift or a major transition in ECG interpretation?

    T Rajini Samuel · Shri Sathya Sai Medical College and Research Institute, India

    Introduction: Electrocardiogram (ECG) has offered immense clinical value for more than a century yet its interpretation remains an arduous task and ECG phobia develops in some of the junior doctors and staff nurses…

  13. Oral

    Anesthetic management of a patient with dilated cardiomyopathy posted for hernioplasty

    Vivek Vaibhav · Saraswathi Institute of Medical Sciences, India

    Dilated cardiomyopathy (DCM) is a myocardial disease characterised by ventricular dilatation and global myocardial dysfunction (ejection fraction < 40%). Patients usually present with symptoms of biventricular failure…

  14. Oral

    Erythrocytes and distribution of the information in the human body

    Merab Beraia · Tbilisi State University, Georgia

    At the beginning of blood flow, red blood cells (RBCs) align in the central plane of the vessels. In capillaries, RBCs change from a biconcave disk to a parachute shape and as blood moves from the arterial to the venous…

  15. Oral

    Harm reduction in smoking: What does the scientific evidence say?

    Cristina Milagre Quadros Borges · Heart Hospital - Hcor, Brazil

    Smoking is considered a chronic disease, caused by chemical dependence of nicotine. This is highly addicting, it in the brain system, it infuences our emotions increases the feeling of pleasure/humor and reduces the…

Day 2

Day 2

  1. Keynote

    Rationale for the prevention or therapy of sudden cardiac death in heart failure

    Naranjan S Dhalla · St. Boniface Hospital Albrechtsen Research Centre, Canada

    Although sudden cardiac death is considered to be a major mode of death in patients with heart failure, no satisfactory medical therapy is available for its prevention. Since over activation of sympathetic nervous…

  2. Keynote

    Cardio nanomedicine: Fighting plaque, opening arteries, and healing hearts

    Thomas J Webster · Brown University, United States

    Nanomedicine has already provided dozens of FDA approved products improving the lives of billions. Most notably, nanomaterials have been used to develop vaccines for COVID, improved spinal implants, anti-infection…

  3. Keynote

    Aortic root replacement

    John R Doty · Intermountain Medical Center, United States

    Aortic root replacement is an operation that requires resection of diseased aortic sinus tissue. Patients requiring aortic root replacement include those with combined aortic valve degeneration and aortic pathology…

  4. Keynote

    Clinical pharmacology of sotagliflozin – Novel quality in treatment of heart failure

    Miroslav Radenkovic · University of Belgrade, Serbia

    Heart failure is a serious clinical syndrome with symptoms and signs provoked by a structural and functional cardiac abnormality, and coupled with elevated natriuretic peptide levels and evident pulmonary or systemic…

  5. Oral

    The clinical profile of myocardial bridge, a study of 25 cases from India

    Nidhish Niranjan Nisty · Nisty Heart Centre, India

    Introduction: Myocardial bridging is congenital coronary anomaly in which a segment of an epicardial coronary artery takes a tunnelled course under a bridge of the myocardium. This segment is compressed during systole…

  6. Oral

    The potential of Machine learning to predict the arterial stiffness from hemodynamics and biomechanics parameters

    Asma Ayadi · Tunisian Center for Nuclear Sciences and Technology, Tunisia

    Arterial stiffness has emerged as a prominent marker of risk for cardiovascular disease. Few studies are interested in predicting symptomatic or asymptomatic arterial stiffness from hemodynamics and biomechanics…

  7. Oral

    Mitral-aortic-tricuspid valve correction in CPB complicated with small cavity of left ventricle

    Volodymyr Popov · NICVS Amosova, Ukraine

    Aim: To determine significance of patient-prosthesis mismatch (PPM) (indexed effective orifice area < 1,2 cm²/m²) after combined mitral-aortic valve replacement (MAVR) + TV`s plasty (TV) in pts with small cavity of left…

  8. Oral

    Wrap or not to wrap of ascending aorta during surgical treatment of its poststenotic aneurysms is it the better option?

    Olexandr Bolshak · Amosov National Institute of Cardiovascular Surgery, Ukraine

    Aim: To research possibilities of surgical treatment of poststenotic aneurysms of ascending aorta (PAAA) by different methods. Methods: During 2000-2023 yy 454 patients (pts) with aortic stenoses (AS) and PAAA were…

  9. Oral

    Arch plasty of left atrium for moderate dilatation of left atrium during MV`s correction: Is it necessary?

    Valery Boukarim · Amosov National Institute of Cardiovascular Surgery, Ukraine

    O bjective. To determined possibillities of left atrium (LA)`s reduction by original method of arch plasty of LA (APLA) during mitral valve replacement (MVR) for isolated mitral valve disease (MVD). Methods. During 2005…

  10. Oral

    Myocardial protection for combined mitral-aortic-tricuspid valve correction: Is retrograde applying of cardioplegia is better?

    Oleksii Gurtovenko · Amosov National Institute of Cardiovascular Surgery, Ukraine

    Objective: To present analysis of retrograde crystalloid cardioplegia during combined valve pathology of mitral-aortic-tricuspid valve disease (matvd) . Materials and Methods: During 2009-2023 yy 529 patients (pts) with…

  11. Oral

    Reconstruction of left part of the heart for combined mitral-aortic-tricuspid valve diseases

    Volodymyr Popov · NICVS Amosova, Ukraine

    O bjective: To determined possibillities of correction of the left parts of the heart by preservation of MV`s apparatus and concomitant reduction of left atrium (LA) during correction of combined mitral-aortic-tricuspid…

  12. Oral

    Mitral stenoses complicated by massive thromboses of left atrium

    Olexandr Bolshak · Amosov National Institute of Cardiovascular Surgery, Ukraine

    Objective: To analyzed main problems in surgery of mitral valve diseases (MVD) complicated by left atrium`s massive thromboses (LAMT) (thromboses more than 1/3 of left atrium`s volume). Materials And Methods 336 adult…

  13. Oral

    Triangular plasty of left atrium for atriomegaly during mitral valve correction: Is it neccesary?

    Valery Boukarim · Amosov National Institute of Cardiovascular Surgery, Ukraine

    O bjective. To determined possibillities of left atrium (LA)`s reduction by original method of triangular plasty of LA (TPLA) during mitral valve replacement (MVR) for isolated mitral valve disease (MVD). Methods.…

  14. Oral

    Pre-and postcondition of coronary artery and myocardium for combined mitral-aortic-tricuspid valve correction

    Oleksii Gurtovenko · Amosov National Institute of Cardiovascular Surgery, Ukraine

    Objective: To present analysis of pharmacological supporting of conditions of coronary artery and myocardium (pre and postcondition) during combined mitral-aortic valve replacement (MVAR) + TV`s plasty . Materials and…

Day 3

Day 3

  1. Keynote · In-Person

    Innovative strategies in cardiovascular medicine: Enhancing spearhead excellence of new molecular entities

    Dae Wook Lee · Novartis Pharmaceuticals, Korea, Republic of

    In the rapidly evolving landscape of healthcare, the role of Medical Affairs (MA) is increasingly pivotal in the successful launch of new molecular entities (NMEs). This abstract delves into the innovative approaches…

  2. Keynote · In-Person

    Investigating the therapeutic efficacy, safety, and long-term impact of sacubitril valsartan in treating hypertrophic cardiomyopathy

    Shenghan Zhong · Chongqing Kanghua Zhonglian Cardiovascular Hospital, China

    Background: This study aims to evaluate the efficacy, safety, and long-term effects of sacubitril/valsartan in treating hypertrophic cardiomyopathy using a hypertrophic cardiomyopathy rat model and in vitro…

  3. Keynote · In-Person

    Does conduction system pacing preserve left ventricular ejection fraction and prevent the development of dyssynchronous cardiomyopathy?

    Grace Qiu · Thomas Jefferson University, United States

    Background : It is well known that conventional right ventricular (RV) pacing results in left ventricular dyssynchrony. Approximately 30% of patients with normal baseline ejection fraction (EF) and >40% of RV pacing…

  4. Oral · Virtual

    Precision medicine for a personalized care in dyslipidaemia

    Syed Raza · Awali Hospital, Bahrain

    Dyslipidaemia comprises of abnormal lipid components and refers mainly to increased levels of LDL, non HDL particles and triglycerides while decreased levels of HDL Dyslipidaemia is a common and independent modifiable…

  5. Oral · Virtual

    Updated recommendations for the management of patients with diabetes mellitus and cardiovascular diseases

    Mekhman N Mamedov · National Research Center for Preventive Medicine, Russian Federation

    WHO considers diabetes mellitus (DM) to be a pandemic that has spread throughout the world. In some countries, this epidemic reaches >8% of the adult population, and in 20 years the frequency is expected to increase to…

  6. Oral · Virtual

    Effects of impaired microcirculation in the musculoskeletal system

    Roger H Coletti · Interventional Health, United States

    Throughout the body blood flow is regulated by vascular tone secondary to local or neurologic control. However, in the musculoskeletal system, the effects of muscular contraction can lead to augmentation of restriction…

  7. Oral · Virtual

    Metabolic dysfunction spilling over to the heart

    Ahdy Wadie Helmy · Indiana University School of Medicine, United States

    Metabolic Dysfunction and Metabolic Syndrome birthed with visceral adiposity, and Insulin resistance has wide spread implications. From a bed of inflammation at the visceral adipose tissue core, RAAS activation and…

  8. Poster

    Downregulation of CACNA2D1 protein is the key event involved in reducing hypertension-induced myocardial injury in exercised mice

    Zuowei Pei · Central Hospital Of Dalian University Of Technology, China

    Hypertensive?HTN? is one of the risk factors for cardiovascular disease, and exercise has a protective effect on the heart. However, the mechanism by which exercise affects HTN-induced myocardial damage is unclear. In…

  9. Poster

    Triglyceride-glucose index is associated with poor prognosis in patients with stable coronary artery disease undergoing coronary artery bypass grafting

    Zhongchen Li · Fuwai Hospital, China

    Background: The triglyceride-glucose (TyG) index, which is a reliable substitute indicator for insulin resistance, has been considered an independent risk factor for long-term outcomes in patients with cardiovascular…

  10. Poster

    Association between transthoracic echocardiography monitoring indicators and the incidence of postoperative acute kidney injury in coronary artery bypass grafting

    Mengyi Liu · Chinese Academy of Medical Sciences, China

    Background: Acute kidney injury (AKI) is a common complication following coronary artery bypass grafting (CABG) surgery, with an incidence of 30-60%, significantly impacting both short-term and long-term mortality. In…

  11. Poster

    Exploring the pathological connection and clinical management of hyperuricemia and atherosclerosis: A literature review-based investigation

    Yin Xiaoyang · Beijing University of Chinese Medicine, China

    Objective: Currently, atherosclerosis and hyperuricemia remain among the most challenging metabolic disorders globally. Extensive epidemiological surveys and clinical studies have indicated a potential pathological link…

  12. Poster

    Hyperuric acid is involved in the progression of adriamycin cardiotoxicity

    Yadi Liu · Beijing University of Chinese Medicine, China

    Objective: Based on the phenomenon of elevated blood uric acid in patients with clinical adriamycin cardiac injury, to explore the effect of high uric acid on the progression of adriamycin cardiotoxicity. Methods…

  13. Poster

    The synergistic effect of the triglyceride-glucose index and lipoprotein(a) on the prediction of major adverse cardiovascular events after coronary artery bypass grafting

    Zhongchen Li · Fuwai Hospital, China

    Background: Lipoprotein(a) has been implicated as a pathogenic risk factor for atherosclerosis and its complications. The triglyceride-glucose (TyG) index, a novel surrogate marker for insulin resistance (IR), has been…

  14. Poster

    Preoperative transthoracic echocardiography to predict postoperative atrial fibrillation following coronary artery bypass grafting

    Mengyi Liu · Chinese Academy of Medical Sciences, China

    Background: Postoperative atrial fibrillation (POAF) is the most common complication following coronary artery bypass grafting (CABG), which increases the risk of stroke and mortality, prolongs the length of hospital…

  15. Poster

    Efficacy of yoga as a health promotion lifestyle method to reduce stress among medical students - A cross sectional study in the scope of preventive cardiology.

    A Jamuna Rani · Sree Balaji Medical College and Hospital, India

    Management of stress by yogic practices like Surya Namaskar, Pranayama and Meditation. Medical education includes the strenuous course load and hectic schedule, most students have a lack of time to take care of health…

  16. Poster

    Outcomes of fenestrated versus non-fenestrated in fontan procedure: A systemic review and meta-analysis

    Prima Abdillah Akbar · Airlangga University, Indonesia

    Introduction: Numerous investigations examining fenestration in the Fontan procedure have presented inconsistent findings regarding its effectiveness in improving surgical outcomes. The objective of this meta -analysis…

  17. Poster

    Acute myocardial infarction as a complication of acute myocarditis against the background of coronavirus infection COVID-19

    Marina A Chichkova · Federal State Budgetary Institution, Russian Federation

    A new coronavirus infection identified by the World Health Organization Committee as COVID-19 ("Coronavirus disease 2019") with the official name of the causative agent of infection – SARS-CoV-2. Some patients develop…

  18. Poster

    Sutureless aortic valve replacement

    Vikram Jitendra · Aberdeen Royal Infirmary, United Kingdom

    Aortic stenosis is the most common valvular disease and has a poor prognosis without surgical treatment. The use of sutureless valves (SV) has been emerging as a promising surgical option in certain patient populations…

  19. Poster

    Graded phenomenon (Yasser's phenomenon): A novel electrocardiographic phenomenon change the arrhythmia directory; retrospective-observational study; research article in cardiology

    Yasser Mohammed Hassanain Elsayed · Egyptian Ministry of Health, Egypt

    Background : Arrhythmias are one of the most serious disorders in cardiovascular and clinical medicine. Understanding the pathogenesis and mechanisms of arrhythmias is very advantageous to the appropriate management and…

  20. Poster

    Factors that impact adherence to physical exercise in individuals with chronic pain

    Joao Rafael De Oliveira Rocha Da Silva · Connect Life Rehabilitation and Performance, Brazil

    Chronic pain is defined as persistent pain for more than three months and can be classified as primary with no known etiology, or secondary pertinent to a pathological process and specific clinical diagnosis.In previous…

  21. Poster

    Bridging economics and behavior for cardiovascular wellness

    Iris Panagiota Efthymiou · Regent College London, United Kingdom

    The pursuit of cardiovascular wellness is of paramount global concern, touching the lives of many individuals and societies. Understanding the intricate interplay between economics and behavior in the context of heart…

  22. Poster

    Heart failure patients: Measuring the effectiveness of a rehabilitation program in relation to physical and mental fatigue, general health and anxiety

    Paraskevi Theofilou · General Hospital of Thoracic Diseases Sotiria, Greece

    Exercise is an important factor of rehabilitation in heart failure patients, improving several indicators of disease prognosis and functional capacity. The aim of the present study was to examine the effect of a…

  23. Poster

    An update on optimisation of cardiovascular health in pregnancy

    Eesha Wahid · Trinity College Dublin, Ireland

    Increased physiological demands coupled with haemodynamic changes occurring during pregnancy pose a unique and significant challenge to the cardiovascular system. Pregnant women are at risk of suffering from the…

  24. Poster

    PCSK9 inhibitors beyond cholesterol regulation

    Maria Borrell · Institut de Recerca Sant Pau - Centre CERCA, Spain

    Atherosclerosis, the leading cause of cardiovascular diseases, is driven by high blood cholesterol levels and chronic inflammation. The disruption of the hepatic interaction between Proprotein Convertase…

  25. Poster

    VPexam in heart failure innovating virtual cardiac care

    James V Cireddu · Case Western University, United States

    Telehealth is a growing field of importance, but the loss of comprehensive physical exam data creates barriers to managing complex heart failure patients. Innovative digital tools such as VPExam Virtual Care combine…

  26. Poster

    Comparative policies in preventative cardiology across the world

    Elizabeth C Ghandakly · Cleveland Clinic Foundation, United States

    Recommendations for the primary prevention of cardiovascular disease (CVD) vary by global region. This variability occurs by nature of different practice guidelines being put forth by separate regional cardiology…

  27. Poster

    The anti-atherosclerotic agent MPE-298 mediates mitochondrial oxidative stress through trafficking of the cluster of differentiation 36 (CD36) receptor in macrophages

    Catherine Le · University of Montreal, Canada

    It is known that oxidized low density lipoproteins (oxLDL) interaction with the cluster of differentiation 36 (CD36)/SR-B2, a scavenger membrane protein, at the surface of macrophages, leads to an internalization of…

  28. Poster

    Integration of palliative care for patients with Congestive Heart Failure (CHF)

    Helen Senderovich · Baycrest Health Sciences, Canada

    Introduction: Congestive heart failure (CHF) is an increasingly prevalent terminal illness in a globally aging population. Despite optimal medical management, prognosis remains poor – a fact seldom communicated to…

  29. Poster

    The benefits of assistive devices and physical activity in cardiac and geriatric patients with peripheral artery disease

    Ayisha Zaka Bashir · University of Nebraska Medical Center, United States

    Peripheral artery disease (PAD) is a cardiovascular disease affecting more than 8.5 million Americans over the age of 40 years and is prevalent in the geriatric cardiology population. PAD is a manifestation of systemic…

  30. Poster

    The effects of local violent crime on cardiovascular disease and risk factors

    Corey Tabit · University of Chicago, United States

    Cardiovascular disease is the #1 killer of adults worldwide, with low-socioeconomic urban patients more severely affected. Social Determinants of Health (SDOH) such as community violence, elements of the built…

  31. Poster

    Application of wavelet leader based analysis to model the heart's electrical activity

    Tahmineh Azizi · Florida State University, United States

    In this study, we explore the possibility that ECG recordings belong to class of multifractal process for which a large number of scaling exponents are required to characterize their scaling structures. We use the BIDMC…

  32. Poster

    Keeping people in rhythm electronically: An overview of cardiac rhythm management devices

    Asma Syed · Brookdale Hospital Medical Center, United States

    Abstract not yet available.

  33. Poster

    Standardization of cardiovascular care using clinical pathways – a practical approach to implementing clinical guidelines and evidence-based medicine

    Corey Tabit · University of Chicago, United States

    While cardiovascular disease remains the most common cause of death worldwide, clinical approaches to the management of common cardiovascular conditions such as heart failure, coronary artery disease, and atrial…

  34. Poster

    Management of arrhythmias in pregnancy

    Samir Rafla · Alexandria University, Egypt

    Most palpitations in pregnancy are benign and usually occur due to atrial or ventricular premature complexes. Careful consideration should be given to the gestation stage and the patient's hemodynamic state. In…

  35. Poster

    Donkey pericardium as a select sourcing to manufacturer percutaneous heart valves: Will decellularization guarantee the long-term durability?

    Robert Guidon · Laval University, Canada

    Background: The donkey pericardium is considered to be a good candidate material for use in the manufacture of percutaneous heart valves based upon its thinness, its low cellularity and its undulating collagen bundles…

  36. Poster

    VPexam in heart failure innovating virtual cardiac care

    Jasmine A Clough · Hiram College, United States

    Abstract not yet available.

Present your research at Heart Congress 2027

Abstract submissions for the 2027 program are open · June 24–26, 2027 · NH Villa Carpegna, Rome.

Submit Abstract →

Join the Heart Congress 2027 delegation

Rome · June 24–26, 2027· Hybrid · in-person & virtual

Register as Delegate →

Attend without presenting.

Chat with us